These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Physiopathology of the dyskinesias induced by L-dopa]. Grandas F; López-Ariztegui N Rev Neurol; 1997 Aug; 25 Suppl 2():S151-6. PubMed ID: 9280682 [TBL] [Abstract][Full Text] [Related]
7. Drug treatments of levodopa-induced dyskinesias. Vale S Lancet; 1999 Aug; 354(9177):511. PubMed ID: 10465195 [No Abstract] [Full Text] [Related]
8. Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease. Merims D; Ziv I; Djaldetti R; Melamed E Lancet; 1999 May; 353(9166):1764-5. PubMed ID: 10347995 [No Abstract] [Full Text] [Related]
9. [Risperidone]. Zolk O; Thürauf N Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745 [No Abstract] [Full Text] [Related]
10. Levetiracetam in L-dopa-induced dyskinesia. Meco G; Fabrizio E; Epifanio A; Di Raimondo G; Vanacore N; Morgante L Clin Neuropharmacol; 2005; 28(2):102-3. PubMed ID: 15795556 [No Abstract] [Full Text] [Related]
11. Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease. Karamanakos PN; Pappas P; Marselos M Pharm World Sci; 2008 Jan; 30(1):1-2. PubMed ID: 17597418 [No Abstract] [Full Text] [Related]
12. Quantitative assessment of dyskinesias in subhuman primates. Brotchie JM; Fox SH Mov Disord; 1999; 14 Suppl 1():40-7. PubMed ID: 10493402 [No Abstract] [Full Text] [Related]
13. Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease. Onofrj M; Paci C; Thomas A J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):605-6. PubMed ID: 9771801 [No Abstract] [Full Text] [Related]
14. Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. Furukawa Y; Filiano JJ; Kish SJ Mov Disord; 2004 Oct; 19(10):1256-8. PubMed ID: 15389992 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacological mechanisms of the treatment of dyskinesias in Parkinson disease]. Jiménez-Jiménez FJ; Molina JA; Ortí-Pareja M Rev Neurol; 1999 May 1-15; 28(9):889-98. PubMed ID: 10390756 [TBL] [Abstract][Full Text] [Related]